Immunogen Inc. (IMGN) PT Lowered to $5 at RBC Capital
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Rating Summary:
5 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
5 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
RBC Capital analyst Kennen MacKay lowered the price target on Immunogen Inc. (NASDAQ: IMGN) to $5.00 (from $6.00) while maintaining an Outperform rating.
- IMGN restructuring adds cash runway for additional Mirv ph3
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
- NetEase.com (NTES) PT Raised to $168 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
